Evidence map›Paper›PMID 23970354›Full record

ArticleBlood2013

A mouse model of hemolytic disease of the newborn.

Chance John Luckey, Leslie E Silberstein

Open access · bronzeAbstract readComment
PubMed Publisher
In one paragraph

Article in Blood, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Chance John LuckeyBrigham and Women's Hospital.
Leslie E Silberstein
Brigham and Women's Hospital · US

Funding

Transcriptional Control of Memory Responses to Red Blood Cell AlloimmunizationR21HL119652 · NHLBI · UNIVERSITY OF VIRGINIA · PI LUCKEY, CHANCE MARION JOHN · 2013 to 2014
$440k
NHLBI NIH HHS R21 HL119652
6 · The paper itself

Abstract

In this issue of Blood, Stowell et al describe a novel mouse model of hemolytic disease of the fetus and newborn (HDFN) that recapitulates many of the key features of human disease.1 Recently, this same group of researchers described a transgenic mouse that expresses the human KEL2 (Chellano) red cell surface protein from the Kell system on red cells, and subsequently demonstrated that Kell differences on transfused blood induce antibody responses and hemolytic transfusion reactions similar to those seen in patients. In this latest report, Stowell et al demonstrate that similar to some patients, Kell differences between mother and father can lead to maternal antibody generation and hemolytic disease in utero. In so doing, they provide experimental confirmation of a long sought after animal model of HDFN.

Indexed as

Models, AnimalAnemia, HemolyticAnimalsErythrocytesFemaleIsoantibodiesKell Blood-Group SystemMalePregnancyIsoantibodiesKell Blood-Group System

Identifiers

PMID23970354
OpenAlexW2023489903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.